Cvs Share Discussion Threads

[1jat] 09/11/2023 13:23

Partly depends on what they find…..if they find higher prices where the company has local monopolies then possibly fines.
More likely to agree remedies such as disposals, limits on concentration of practice ownership (bit like supermarkets)
Also more paperwork and price disclosures telling people they can shop around. (But if your animal has a prescription you want it filled asap so I am not sure that saving a few pounds and waiting a few days for a postal delivery really helps).

[essentialinvestor] 04/11/2023 13:44

The investigation in to pricing continues to weigh really heavily -
how bad could the outcome be - could we potentially be looking at hesfty fines, depening on the outcome ..financial redress to customers ?

[ariane] 03/11/2023 07:17

Posting of Annual Report and Notice of Annual General Meeting

CVS, one of the UK's leading providers of integrated veterinary services, announces that its Annual General Meeting ("AGM") will be held at The Pennoyer Centre, Station Road, Pulham St Mary, IP21 4QT on 29 November 2023 at 11:00am.

[travis2] 27/10/2023 12:48

Ah, ok. Just seen the article.

[lomax99] 27/10/2023 08:55

Hope he is felling better soon. Added a few.

[bulltradept] 27/10/2023 07:54

Now we know the reason for the fall.

[travis2] 26/10/2023 19:45

Not invested but considering jumping on board at some point.

[bulltradept] 26/10/2023 12:43

Anyone else still in this? I'm wondering if we are going to get another slap down this week?

[bulltradept] 25/10/2023 16:41

True, but drafts, people talk, brown envelope's etc etc.

[babbler] 25/10/2023 15:48

Report not due until "early next year" so highly unlikely.

[bulltradept] 25/10/2023 14:26

Finger's crossed.

[lomax99] 25/10/2023 14:01

Doubt it, more like general market malaise, down on low volume.

[bulltradept] 25/10/2023 13:49

Someone leaked a draft report of the findings then?

This drip drip drip isn't boding well...

[bulltradept] 04/10/2023 08:26

Strong support around £15.

[waldron] 01/10/2023 13:17

se81
1 Oct '23 - 09:49 - 806 of 806
0 0 0


Tipped in The Times

“The shares are trading at a forward price/earnings multiple of under 16 for 2023 — lower than historic averages and also throwing open the prospect of an opportunistic private equity bid.”

[se81] 01/10/2023 09:49

hxxps://www.thetimes.co.uk/article/share-tip-cvs-vet-chain-should-keep-investors-purring-8nk25d037

Tipped in The Times

“The shares are trading at a forward price/earnings multiple of under 16 for 2023 — lower than historic averages and also throwing open the prospect of an opportunistic private equity bid.”

[wad collector] 22/9/2023 12:52

Independent vets are increasingly being wound up in red tape that encourages the passing on of some of that burden to a group along with a decreased willingness of younger vets to take on the hassle of practice partnership and it's responsibilities , particularly the out of hours . They lose some control of their work environment but it is easier to walk away from a salaried post than a partnership if things don't work out or the job gets worse. It is hard to get any vets to become partners at the moment ,especially if there is much large animal work.
There are areas where takeovers effectively create a monopoly and that is a different problem , otherwise there is market choice to the customers.

[baracuda2] 21/9/2023 18:05

Just like all veterinary groups

[baracuda2] 21/9/2023 18:03

Obviously over charging then!

[kalai1] 21/9/2023 13:43

CVS Group posted impressive Final Results for the year 30th June this morning. Revenue was up 9.8% to £608.3m, operating profit was up 45.6% to £62.3m, basic EPS was up 62.4% to £58.8m. Adjusted numbers were less stellar but still solid with adjusted EBITDA up 13% to £121.4m, adjusted EPS up 11.9% to 96p. The balance sheet remains solid despite the fact that Leverage increased to 0.73x as a result of the acquisition of Quality Pet Care Ltd. Net debt was up to £74m. Valuation is starting to look quite attractive with forward PE ratio at 15.9x, which is comfortably below the 23.6x trailing 12-month low for the share since FY17. The share price lacks positive momentum following its early September collapse following the Competition and Markets Authority launch of a review into the UK veterinary services market for household pets. CVSG remains a share to monitor for the time being, but company specific factors point to an increasingly attractive investment case...

...from WealthOracle

[wad collector] 21/9/2023 10:13

The CMA cannot solve the problem that there is a shortage of vets and their pay is not enticing to stay in the profession , so although they can clamp down on overcharging for some items, they cannot reduce overall profit without worsening the shortage. So providing CVS is not an outlier, it is hard to see that it can suffer much , whatever the CMA says.
So happy to hold.

[babbler] 21/9/2023 09:26

Once the seller has done offloading. Probably some idiotic ii that has "targets" to meet and stops.

[bulltradept] 21/9/2023 08:58

Solid recovery stock up until £17.5 AIMHVO.

[ariane] 21/9/2023 08:03

CVS Group Reports Higher FY23 Profit, Revenue
September 21, 2023 at 02:35 am EDT

(MT Newswires) -- CVS Group (CVSG.L) on Thursday reported year-over-year growth in profit and revenue for fiscal 2023.

Profit for the year ended June 30 was 41.9 million pounds sterling, compared with 25.7 million pounds a year ago. EPS was 0.585 pound, compared with 0.359 pound.

The UK veterinary group's revenue was 608.3 million pounds, compared with 554.2 million pounds previously.

Analysts polled by Visible Alpha were expecting 65.4 million pounds in net income or 0.91 pound per share, while revenue was estimated at 605.8 million pounds.

Meanwhile, the board proposed a final dividend of 0.075 pound per share for the period, payable on Dec. 8. It paid 0.070 pound per share a year ago.

The stock rose nearly 1% in on Wednesday's close.

Price (GBP): £1509.00, Change: £+13.00, Percent Change: +0.87%